540eP CD34-stained microvessel density as a biomarker for predicting immune checkpoint inhibitor efficacy in metastatic non-squamous non-small cell lung cancer: A retrospective study

Authors: E. Cerme, S. Batur, C. Yol et al.
Publication: ESMO Open
Published: Apr 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Prognostic Value of Microvessel Density at the Boundary of Invasive Breast Cancer Patients Based on Multiphoton Microscopy

Liqin Zheng, Jianping Huang et al. - Jul 2026

Read More
AI-based framework pipeline for stromal tumor infiltrating lymphocytes quantification in H&E stained breast cancer histopathological images

Shrief Abdelazeez, Alessio Fiorin et al. - Jul 2026

Read More
The gene encoding interleukin-38, IL1F10, showed down-regulated expression in acute myeloid leukemia particularly in CD34-positive newly diagnosed patients

Mustafa A. Bashi, Mohammed K. Al-Qayyim et al. - Jun 2026

Read More
Advances in In Vitro Vascularization of Engineered Tissues: From Microvessel Formation to Hepatic Tissue Integration

Yen-Hsiang Huang, Akira Ono et al. - Jun 2026

Read More
High-dose chemotherapy and transplantation of autologous CD34+ selected stem cells for progressive systemic sclerosis adjusted to cardiac and lung manifestation: An open-label, non-inferiority phase 2 trial

Ann-Christin Pecher, Ina Koetter et al. - May 2026

Read More